https://api.elsevier.com/content/article/pii/S1473309917302402doi:10.1016/S1473-3099(17)30240-21-s2.0-S147330991730240210.1016/S1473-3099(17)30240-2S1473-3099(17)30240-2Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial The Lancet Infectious DiseasesJournal147330992017-08-31August 20171trueFullfalseWorld Health OrganizationFundingBodyhttp://creativecommons.org/licenses/by/3.0/igo/